Hong Kong-listed Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialisation of innovative therapeutics, has announced that its wholly-owned subsidiary, EverSea Medicines (Singapore), has entered [...]